These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3724801)

  • 1. Postmenopausal estrogen use and heart disease.
    N Engl J Med; 1986 Jul; 315(2):131-6. PubMed ID: 3724801
    [No Abstract]   [Full Text] [Related]  

  • 2. Menopause and the risk of coronary heart disease in women.
    Colditz GA; Willett WC; Stampfer MJ; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1987 Apr; 316(18):1105-10. PubMed ID: 3574358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of postmenopausal estrogen therapy and coronary heart disease.
    Stampfer MJ; Willett WC; Colditz GA; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1985 Oct; 313(17):1044-9. PubMed ID: 4047106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of estrogen treatment in prevention of ischemic heart disease in menopausal women].
    Roig Minguell E
    Rev Esp Cardiol; 1994; 47 Suppl 3():22-6. PubMed ID: 7816976
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimated gains in life expectancy with use of postmenopausal estrogen therapy: a decision analysis.
    Zubialde JP; Lawler F; Clemenson N
    J Fam Pract; 1993 Mar; 36(3):271-80. PubMed ID: 8454973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of coronary heart disease in women after menopause.
    Bulliyya G
    J Indian Med Assoc; 2001 Sep; 99(9):478-80, 482. PubMed ID: 12018552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogens, lipids, and heart disease.
    Barrett-Connor E; Miller V
    Clin Geriatr Med; 1993 Feb; 9(1):57-67. PubMed ID: 8443740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen therapy during menopause.
    Horwitz DL
    Compr Ther; 1980 Mar; 6(3):3-4. PubMed ID: 7363581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern trends in substitutive estrogen therapy in the postmenopausal period. B. Results of the use of an estro-progestogenic association].
    Bubani V; Sansa G
    Ann Ostet Ginecol Med Perinat; 1968 Jul; 90(7):453-96. PubMed ID: 5712636
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of hormone replacement therapy.
    Crosignani PG
    Int J Fertil; 1992; 37 Suppl 2():98-103. PubMed ID: 1354665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of natural estrogen/gestagen and thiazide on cardiovascular risk factors in normal menopausal women. A 2-year double-blind placebo study].
    Christiansen C; Christensen MS; Jensen J; Hagen C; Stocklund KE; Transbøl I
    Ugeskr Laeger; 1981 Aug; 143(35):2230-4. PubMed ID: 7303230
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormones and heart disease.
    Kent S
    Geriatrics; 1979 Jun; 34(6):97-102. PubMed ID: 447079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
    Kiel DP; Felson DT; Anderson JJ; Wilson PW; Moskowitz MA
    N Engl J Med; 1987 Nov; 317(19):1169-74. PubMed ID: 3657888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement therapy and benign breast disease.
    Trapido EJ; Brinton LA; Schairer C; Hoover R
    J Natl Cancer Inst; 1984 Nov; 73(5):1101-5. PubMed ID: 6092767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.